Gary, earlier this month you mentioned PRZ. The more I look at them the more I like'em. They won't interest many here because there is 41M shares out and it's at $3. However, I think it has all the qualities of a future star.
It's also the poster child for a good forward statement.
Mark Szporka, Chief Financial Officer of PainCare, stated, "We believe that 2004
will be yet another outstanding year for PainCare. Most notably, the organic
growth we have achieved in the practices that we've acquired -- specifically
those who have been on board with PainCare for over 12 months, is reflecting, on
average, a 47% increase in operating income. We believe that this solidly
confirms that our strategy to diversify and enhance a practice's service
offerings is working and working very well."
Continuing, Szporka added, "With regard to our financial guidance, I am pleased
to report that PainCare is firmly on pace to achieve $35 to $36 million in
revenue, $10 to $10.5 million in operating income, $5.5 to $6 million in net
income and $.14 to $.15 per fully diluted share in earnings in 2004. Based on
the ongoing successful execution of our business plan, we expect to achieve $59
to $60 million in revenue, $23 to $24 million in operating income, $14 to $14.5
million in net income and $.24 to $.25 earnings per fully diluted share in
2005."
PainCare's Chief Executive Officer, Randy Lubinsky, said, "As evidenced by our
third quarter performance, we continue the steadfast execution of our model --
grow revenues, maintain expense discipline, expand margins and enhance earnings.
With nine consecutive quarters of record results, we are accumulating a strong
track record and continue to build the Company for success in all market
environments. Given the proceeds from our Company's first public offering
completed in early October 2004, we have sufficient resources to pursue our
growth objectives in the coming year. Moreover, the offering has delivered a
series of value-added benefits to our Company, not the least of which include
enhanced liquidity in our stock through increased public float, analyst
sponsorship from two highly respected investment banking firms on Wall Street,
and many new high-quality institutional shareholders. Although 2004, by any
measure, is shaping up to be a landmark year for PainCare, 2005 is expected to
be even stronger." |
